<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02793206</url>
  </required_header>
  <id_info>
    <org_study_id>327/2011 BO</org_study_id>
    <nct_id>NCT02793206</nct_id>
  </id_info>
  <brief_title>Spectral Domain OCT Imaging in Patients With Optic Nerve Head Drusen (Tuebingen SD-OCT IN OPTIC NERVE HEAD DRUSEN STUDY)</brief_title>
  <acronym>TODS</acronym>
  <official_title>Spectral Domain Optic Cohaerence Tomography Imaging in Patients With Optic Nerve Head Drusen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Optic nerve head Drusen are a mostly bilateral change of the optic nerve, eventually causing
      a slow, but progression loss of the visual fields. Characteristic are the crystalline
      deposits at the entrance of the optic nerve, the so called optic disc. The material consists
      of calcium, calcium phosphate, iron, but also amino acids and polysaccharides.

      The diagnose is made or confirmed by different imaging modalities like ultrasound and
      auto-fluorescence imaging. By using the high-resolution imaging with spectral-domain optical
      coherence imaging (SD-OCT) the volume and deposits at the optic disc can be measured and
      quantified.

      The purpose of this study whether and how defects in the visual fields are related to the
      deposits. Multimodal imaging of the optic nerve head is planned within the cross-sectional
      study, at two different time intervals (2 years). Changes in retinal fibre layer (RNFL)
      thickness and disc parameters are analyzed. Presence and extent of auto-fluorescent changes
      are evaluated. The prospective trial wants to clarify whether certain parameters at baseline
      indicate the further outcome and development.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2011</start_date>
  <completion_date type="Actual">May 1, 2017</completion_date>
  <primary_completion_date type="Actual">September 1, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in RNFL thickness</measure>
    <time_frame>baseline and 2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Loss of Visual Fields</measure>
    <time_frame>baseline and 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in auto-fluorescent areas</measure>
    <time_frame>baseline and 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Drusen material</measure>
    <time_frame>baseline and 2 years</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">35</enrollment>
  <condition>Optic Disc Drusen</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Imaging</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Optic Disc Drusen
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with Drusen of the optic disc (as proven by ultrasound and clinical
             appearance)

        Exclusion Criteria:

          -  mental disability

          -  loss of fixation

          -  other eye diseases potentially leading to a loss of visual fields
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Tuebingen</city>
        <state>BW</state>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Asensio-Sánchez VM, Trujillo-Guzmán L. SD-OCT to distinguish papilledema from pseudopapilledema. Arch Soc Esp Oftalmol. 2015 Oct;90(10):481-3. doi: 10.1016/j.oftal.2015.05.001. Epub 2015 Jul 3. English, Spanish.</citation>
    <PMID>26148443</PMID>
  </reference>
  <reference>
    <citation>Casado A, Rebolleda G, Guerrero L, Leal M, Contreras I, Oblanca N, Muñoz-Negrete FJ. Measurement of retinal nerve fiber layer and macular ganglion cell-inner plexiform layer with spectral-domain optical coherence tomography in patients with optic nerve head drusen. Graefes Arch Clin Exp Ophthalmol. 2014 Oct;252(10):1653-60. doi: 10.1007/s00417-014-2773-5. Epub 2014 Aug 17.</citation>
    <PMID>25128962</PMID>
  </reference>
  <reference>
    <citation>Pilat AV, Proudlock FA, Kumar P, Lee H, Papageorgiou E, Gottlob I. Macular morphology in patients with optic nerve head drusen and optic disc edema. Ophthalmology. 2014 Feb;121(2):552-7. doi: 10.1016/j.ophtha.2013.09.037. Epub 2013 Nov 14.</citation>
    <PMID>24238882</PMID>
  </reference>
  <reference>
    <citation>Sato T, Mrejen S, Spaide RF. Multimodal imaging of optic disc drusen. Am J Ophthalmol. 2013 Aug;156(2):275-282.e1. doi: 10.1016/j.ajo.2013.03.039. Epub 2013 May 12.</citation>
    <PMID>23677136</PMID>
  </reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2016</study_first_submitted>
  <study_first_submitted_qc>June 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2016</study_first_posted>
  <last_update_submitted>December 22, 2017</last_update_submitted>
  <last_update_submitted_qc>December 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Drusen</keyword>
  <keyword>SD-OCT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Optic Disk Drusen</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

